Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million from Germantown, Maryland’s Orgenesis Inc.

Published on :

February 03, 2020 07:29 AM Eastern Standard Time SOMERSET, N.J. & GOSSELIES, Belgium–(BUSINESS WIRE)–Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, and MaSTherCell Global, Inc., a technology-focused cell and gene therapy contract development and manufacturing organization to leading [….]

New Immuno-Oncology Startup out of Baltimore Launches at JPM Healthcare Conference with Veteran Board, Advisors and Officers

Published on :

New Immuno-Oncology Startup out of Baltimore Launches at JPM Healthcare Conference with Veteran Board, Advisors and Officers VerImmune’s Novel technology platform enables redirection of pre-existing natural immunity towards fighting cancer BALTIMORE (Originally Published via PRWEB) JANUARY 13, 2020 VerImmune Announces New Board, Advisors and Officers VerImmune, a privately-owned immuno-oncology biotechnology company developing a first-in-class broad spectrum [….]

Unknown Future for Frederick Vaccine Company After Recent Acquisition by General Dynamics

Published on :

Unknown Future for Frederick Vaccine Company After Recent Acquisition by General Dynamics General Dynamics acquires CSRA for $9.6 Billion Among the giant Federal Government defense contractors that line the DC beltway there is a small business unit within CSRA that resides out in Frederick, MD. As the sole life science business within the larger conglomerate, DynPort Vaccine Company (DVC) manages vaccine product develop for Federal biodefense and [….]